Skip to content
10-Q

Quarterly Report

Evolent Health, Inc. EVH

0001628908-25-000133

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 111.6M sh
Shares Diluted Q3 2025 · Sep 30, 2025 114.07M sh
Shares Diluted Q3 2025 · Sep 30, 2025 115.08M sh
Shares Diluted Q3 2025 · Sep 30, 2024 114.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 114.57M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $40M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$9.96M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $45M
Long Term Debt Q3 2025 · Sep 30, 2025 $1.05B
Long Term Debt Q3 2025 · Dec 31, 2024 $490.52M
Short Term Debt Q3 2025 · Sep 30, 2025 $5.12M
Short Term Debt Q3 2025 · Dec 31, 2024 $171.47M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $116.65M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $104.2M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $96.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 $842.23M
Stockholders Equity Q3 2025 · Jun 30, 2025 $896.01M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.04B
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.05B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.07B
Current Liabilities Q3 2025 · Sep 30, 2025 $429.93M
Current Liabilities Q3 2025 · Dec 31, 2024 $715.5M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.61B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.35B
Current Assets Q3 2025 · Sep 30, 2025 $570.09M
Current Assets Q3 2025 · Dec 31, 2024 $607.12M
Total Assets Q3 2025 · Sep 30, 2025 $2.45B
Total Assets Q3 2025 · Dec 31, 2024 $2.54B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.24
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.31
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.55
Eps Basic Q3 2025 · Sep 30, 2025 −$0.24
Eps Basic Q3 2025 · Sep 30, 2025 −$1.31
Eps Basic Q3 2025 · Sep 30, 2024 −$0.27
Eps Basic Q3 2025 · Sep 30, 2024 −$0.55
Sga Expense Q3 2025 · Sep 30, 2025 $77.59M
Sga Expense Q3 2025 · Sep 30, 2025 $231.21M
Sga Expense Q3 2025 · Sep 30, 2024 $67.06M
Sga Expense Q3 2025 · Sep 30, 2024 $215.35M
Net Income Q3 2025 · Sep 30, 2025 −$20.86M
Net Income Q3 2025 · Sep 30, 2025 −$105.38M
Net Income Q3 2025 · Sep 30, 2024 −$23.14M
Net Income Q3 2025 · Sep 30, 2024 −$38.82M
Operating Income Q3 2025 · Sep 30, 2025 $886K
Operating Income Q3 2025 · Sep 30, 2025 −$1.91M
Operating Income Q3 2025 · Sep 30, 2024 −$16.27M
Operating Income Q3 2025 · Sep 30, 2024 −$21.89M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $379.76M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.1B
Cost Of Revenue Q3 2025 · Sep 30, 2024 $540.71M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.62B
Revenue Q3 2025 · Sep 30, 2025 $479.53M
Revenue Q3 2025 · Sep 30, 2025 $1.41B
Revenue Q3 2025 · Sep 30, 2024 $621.4M
Revenue Q3 2025 · Sep 30, 2024 $1.91B